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Quality Control During
Aminoacyl-tRNA Synthesis
M. Prætorius-Ibba,* S. Ataide,* C. Hausmann,*
J. Levengood,** J. Ling,** S. Wang,* H. Roy,* and M. Ibba*,**
* Department of Microbiology, ** Ohio State Biochemistry Program,
The Ohio State University, Columbus, Ohio 43210-1292, USA
The fidelity of translation is determined at two major points: the accuracy of aminoacyl-tRNA
selection by the ribosomes and synthesis of cognate amino acid/tRNA pairs by aminoacyl-tRNA
synthetases (aaRSs) in the course of the aminoacylation reaction. The most important point in
aminoacylation is the accurate recognition of cognate substrates coupled with discrimination of
non-cognates. While this is generally accomplished by a single enzyme, we have recently found
that discrimination against lysine analogues requires the existence of two unrelated lysyl-tRNA
synthetases. For other amino acids, initial recognition is not sufficiently accurate with errors being
corrected by an intrinsic editing activity. Recent studies indicate how editing prevents the misin-
terpretation of phenylalanine as tyrosine in the genetic code and have shown the importance of
this process in vivo. More recent studies indicate that while these editing reactions are critical in
the cytoplasm, some are absent from mitochondria suggesting that the overall fidelity of protein
synthesis might be reduced in this compartment.
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Introduction
The correct functioning of living systems requires maintai-
ning a certain level of fidelity in all processes dealing with
the transfer of information. Translation is the process by
which genetic information is transferred from a nucleic acid
sequence into the amino acid sequence of a protein. The fi-
delity of translation is determined at two major points: the
accuracy of aminoacyl-tRNA (aa-tRNA) selection by the
ribosomes and synthesis of cognate amino acid/tRNA pairs
in the course of the aminoacylation reaction. Aminoacyl--
tRNAs are made by the aminoacyl-tRNA synthetases
(aaRSs), a family of twenty proteins each of which pairs a
particular amino acid with the correct tRNA, thereby defi-
ning the genetic code.1,2 After aa-tRNAs are synthesized
they are screened by elongation factor Tu3 (EF-Tu) which
also delivers them to the ribosome where further checking
may also occur4 (Fig. 1). Quality control steps after aa-tRNA
synthesis are not sufficient on their own to completely pre-
vent aminoacylation errors from being propagated during
translation. This focus of quality control on aa-tRNA synthe-
sis has allowed the design of in vitro systems for the site-spe-
cific co-translational insertion of synthetic amino acids in
response to in-frame stop codons.5-8 These systems all rely
on aaRSs with modified substrate specificities9 and no other
modifications to the cellular protein synthesis machinery
are necessary for their function. The ability to manipulate
the genetic code in such a straightforward way illustrates
the pivotal contribution of quality control to translational fi-
delity during aa-tRNA synthesis.
Quality control and aminoacyl-tRNA
The synthesis of non-cognate aa-tRNAs is potentially cata-
strophic for cellular viability. A variety of quality control
strategies are employed by the cell to ensure that typically
only about one in every 104 codons is mistranslated, even
though much higher rates can be tolerated at some co-
dons.10-12 In addition to codon-anticodon pairing,13 the
mechanisms of translational quality control are broadly of
three types; specificity of substrate selection by aa-tRNA
synthetases, proofreading, and exclusion from the ribo-
some. Exhaustive studies over the last four decades have
described in intricate detail the molecular recognition stra-
tegies, that allow synthetases to select particular canonical
amino acids and tRNAs to generate correctly matched
aa-tRNAs (reviewed in Ibba and Söll, 2000). These include a
variety of different editing mechanisms designed to ensure
that misactivated amino acids or mischarged aa-tRNA will
be hydrolyzed.14-17 It has recently become clear that amino
acid specificity is also enhanced by the existence of a natu-
ral reservoir of diverse synthetase alleles. This pool of synt-
hetases displays differences in specificity towards molecules
outside the canonical set of amino acids and can exclude
amino acid analogues from translation18 and provide resi-
stance against inhibitory amino acid mimics.19 Representa-
tive examples of several of the strategies for quality control
during aa-tRNA synthesis are discussed in more detail
below.
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Substrate discrimination
by lysyl-tRNA synthetase
AaRSs can be divided into two structurally unrelated clas-
ses, I and II, with 10 canonical members in each.20 The
divergent structures lead to functional differences with re-
spect to ATP and tRNA binding in each class.21 An aaRS
from each class is designated to each amino acid with
only one exception known to date, lysyl-tRNA synthetase22
(LysRS), for which examples from, both, class I (LysRS1) and
class II (LysRS2) are known. Analysis of the distribution of
LysRS has so far shown that LysRS2 is found in all eukaryo-
tes, most bacteria and some archaea, and LysRS1 is present
in some bacteria and most archaea.23,24 LysRS1 and LysRS2
are not generally found together, their co-existence being
restricted to a few organisms. Although, structurally diffe-
rent, LysRS1 and LysRS2 are able to recognize lysine and
tRNALys in vivo and in vitro in much the same way. For
example, the elements recognized by, both, LysRS1 and
LysRS2 in tRNALys are the same, namely the anticodon,
acceptor stem, and discriminator bases.25-27 In contrast, the
activation mechanism for lysine is significantly different
between each LysRS. LysRS2 forms lysyl-adenylate after
binding only lysine and ATP, while LysRS1 additionally re-
quires the prior binding of tRNALys. tRNA binding prior to
amino acid activation is a feature shared by only a small
sub-group of class I aaRS.28-30 The crystal structures of
LysRS1 and LysRS2 complexed with lysine reveal, that whi-
le the mechanisms of recognition of the R-group of L-lysine
rely on similar arrangements of amino acids in each binding
pocket, the active sites are different31 (Fig. 2). These structu-
ral differences lead to divergent patterns in non-cognate
substrate discrimination between LysRS1 and LysRS2.18,32
Based on the structure of L-lysine complexed with E. coli
LysRS2 (lysS), residues implicated in amino acid recognition
and discrimination were systematically replaced. Steady-
state kinetic parameters for these variants showed reduc-
tions in the catalytic efficiency (kcat / KM) of 1 to 3 orders of
magnitude, allowing the assignment of specific roles for key
residues in the active site of LysRS2. To further investigate
the role of each residue in discrimination against non-
cognate amino acids, steady-state kinetic parameters were
determined for the non-protein amino acid S-(2-amino-
ethyl)-L-cysteine, a potent inhibitor of LysRS2. While a
number of variants showed reductions of several hundred
fold in efficiency of S-(2-aminoethyl)-L-cysteine utilization,
this was uniformly accompanied by similar reductions in
the efficiency of lysine utilization. Thus, manipulation of the
amino acid binding site only allowed up to a four fold im-
provement in S-(2-aminoethyl)-L-cysteine discrimination.33
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F i g. 1 – Translation of the codon AAA as lysine during the elongation phase of protein synthesis. Uncharged tRNALys and lysine are first
selected from the cellular pools of similar molecules by lysyl-tRNA synthetase (LysRS). After synthesis and release from LysRS, lysyl-tRNALys is
delivered to the ribosome, where its anticodon can then interact with the corresponding codon in mRNA.
S l i k a 1 – Translacija kodona AAA kao lizina za vrijeme elongacijske faze u sintezi proteina. Nenabijena tRNALys i lizin najprije su selektira-
ni iz celularne skupine sliènih molekula pomoæu lizil-tRNA sintetaze (LyRS). Nakon sinteze i oslobaðanja iz LysRS, lizil-tRNALys dolazi do ribo-
soma, gdje njegov anti-kodon tada moÞe reagirati s odgovarajuæim kodonom u mRNA.
F i g. 2 – L-lysine recognition by LysRS1 and LysRS2. L-lysine in
the active site of Pyrococcus horikoshii LysRS131 (left panel) and
Escherichia coli LysRS271 (right panel).
S l i k a 2 – LysRS1 i LysRS2 prepoznaju u aktivnom mjestu Py-
rococcus horikoshii LysRS131 (lijevo) i Escherichia coli LysRS271
(desno).
This is in contrast to the highly effective discrimination
against S-(2-aminoethyl)-L-cysteine by class I LysRS, and
correlates with the fundamentally different roles of conser-
ved aromatic residues in the two LysRS active sites. These
data indicate that the lysine-binding site is more open
in LysRS2 than in LysRS1, in agreement with previous
structural studies. The physiological significance of diver-
gent amino acid recognition was reflected by the in vivo re-
sistance to growth inhibition imparted by LysRS1 against
S-(2-aminoethyl)-L-cysteine and LysRS2 against -amino bu-
tyric acid. These differences in resistance to naturally occur-
ring non-cognate amino acids illustrate how the distribution
of LysRS1 and LysRS2 contributes to quality control during
protein synthesis by excluding lysine analogues.
Editing of misactivated tyrosine
by phenylalanyl-tRNA synthetase
The accuracy of aa-tRNA synthesis is generally assured by
the existence of aaRSs specific for each particular amino
acid:tRNA pair, as for example in the case of LysRS descri-
bed above. Cognate tRNA recognition, and discrimination
of non-cognate RNAs, is achieved by sequence-specific di-
rect and indirect readout of the numerous combinations of
bases present in tRNAs.34-37 The relative structural simplicity
of the amino acid substrates makes their accurate recogni-
tion and discrimination more challenging. While some ami-
no acids, such as cysteine and tyrosine (Tyr), are distinct
enough to allow their specific recognition by a particular
aaRS,38,39 others, such as valine and isoleucine, are less
easily distinguished. For example the class I aaRS isoleucyl-
tRNA synthetase (IleRS) is only able to poorly discriminate
against valine, which has a misactivation rate of about
1:200 compared to the cognate substrate isoleucine. De-
spite this significant rate of misactivation and misaminoacy-
lation, the accuracy of translation is not compromised due
to the existence of an intrinsic proofreading and editing me-
chanism in IleRS, that specifically hydrolyzes both misacti-
vated Val-AMP and misaminoacylated Val-tRNAIle.14,40 In
addition to IleRS, it has been found that many other class I
and class II aaRSs also employ editing to prevent release of
non-cognate aa-tRNA and subsequent loss of translational
accuracy (reviewed in41,42). With a few notable excep-
tions,43 editing generally occurs in specialized domains
distal from the active site such as the class I specific CP1 re-
gion of IleRS, leucyl- (LeuRS) and valyl-tRNA synthetases
(ValRS). The editing domains of class II aaRSs are more
diverse than their class I counterparts and include the
“HxxxH” domain found in, both, alanyl-44 and threonyl-
tRNA synthetase (ThrRS),15 an unrelated domain in archaeal
ThrRS,45,46 and a Ybak-like domain in prolyl-tRNA syntheta-
se (ProRS).47-49
The editing domains of aaRSs are normally found in the
same polypeptide as the active site, the only exceptions
being trans-editing enzymes that are believed to compen-
sate for the lack of editing in some archaeal ThrRSs and
bacterial ProRSs and PheRS. PheRS is usually an ()2 hete-
rotetramer, with the active site located in the -subunit and
tRNA binding sites in both subunits. Phenylalanyl-tRNA
synthetase mis-activates tyrosine and subsequently corrects
such errors through hydrolysis of tyrosyl-adenylate and
Tyr-tRNAPhe. Structural modeling combined with an in vivo
genetic screen identified the editing site in the B3/B4
domain of the -subunit, 40 Å from the active site in the
-subunit.50 Replacements of residues within the editing site
had no effect on Phe-tRNAPhe synthesis but abolished
hydrolysis of Tyr-tRNAPhe in vitro. Expression of the corre-
sponding mutants in Escherichia coli significantly slowed
growth, and changed the activity of a recoded -galacto-
sidase variant by misincorporating tyrosine in place of phe-
nylalanine. This loss in aromatic amino acid discrimination
in vivo revealed that editing by phenylalanyl-tRNA synthe-
tase is essential for faithful translation of the genetic code.
It is less clear whether mitochondrial PheRSs also have the
potential to edit misacylated tRNAs, as they are monomers
and thus lack the conventional ()2 oligomeric form.51,52
Mitochondrial PheRS sequences are most closely related to
the bacterial-type, and are chimeras of the -subunit with
an inserted domain between motifs 2 and 3, and the
C-terminal tRNA anticodon binding domain (B8) of the
-subunit.51 Despite their similarity to bacterial PheRSs, the
mitochondrial versions do not contain regions analogous to
the known editing domain.50 While it was originally sug-
gested that mitochondrial PheRSs were active in editing,53
later studies questioned these findings.51 Yeast cytoplasmic
PheRS contains an editing site functionally analogous to
that of Escherichia coli, and disruption of the site abolishes
editing of Tyr-tRNAPhe, both, in cis and trans but does not
diminish Phe-tRNAPhe synthesis. Wild-type mitochondrial
PheRS lacks both cis and trans editing and can synthesize
Tyr-tRNAPhe, an activity enhanced in active site variants with
improved tyrosine recognition. These findings indicate that
the mitochondrial protein synthesis machinery lacks the ty-
M. PRÆTORIUS-IBBA et. al: Quality Control During Aminoacyl-tRNA Synthesis, Kem. Ind. 55 (3) 129–134 (2006) 131
F i g. 3 – Model for RNA-dependent editing by phenylalanyl-
tRNA synthetase. The 3’-end of tRNAPhe is shown in the active site
(AS) as depicted in the crystal structure,72 and modeled into the
editing site (ES).
S l i k a 3 – Model za ureðivanje ovisno o RNA pomoæu fenilala-
nil-tRNA-sintetaze. Pokazan je 3’-završetak tRNAPhe u aktivnom
mjestu (AS) kao što je opisan u kristalnoj strukturi72, i modeliran na
ureðivaèko mjesto (ES).
rosine proofreading activity characteristic of cytoplasmic
translation. Functional analyses and sequence-based pre-
dictions suggest that other non-cognate aa-tRNA editing
pathways, such as that for Ile-tRNALeu, 54 may also be absent
from mitochondria. These differences between mitochon-
drial and cytoplasmic aaRS functions suggest that, either
organelle protein synthesis quality control is focused on
another step, or that translation in this compartment is inhe-
rently less accurate.
Higher order complexes
in aminoacyl-tRNA synthesis
In bacteria aaRSs typically perform their role as individual
enzymes, found either as monomers, homo-dimers, or ho-
mo- or hetero-tetramers. However, in eukaryotes several
aa-tRNA synthetases exist in multi-enzyme complexes55-57
and two different types have so far been found in mamma-
lian cells. One is composed of only one aaRS, ValRS, and
EF-1H, the heavy form of translation elongation factor 1.58
The second complex is considerably larger and includes
nine aaRSs, IleRS, leucyl-(LeuRS), prolyl-(ProRS), methio-
nyl-(MetRS), glutaminyl-, glutamyl-(GluRS), LysRS, arginyl-,
and aspartyl-(AspRS) tRNA synthetases. In addition, the
polypeptide carrying the ProRS activity is multi-functional
in that the protein also comprises the catalytic domain and
activity of GluRS.59 Three auxiliary proteins, p18, p38, and
p43 are also part of the multi-synthetase complex. Although,
the structural and functional significance of the complex
still remains to be elucidated, it is known that N- and C-ter-
minal extensions of the mammalian synthetases mediate
association of the components. The accessory components
p18, p38 and p43 assist complex formation and stability,
and promote tRNA binding by the complex.60-62
The only other multi-aaRS complex so far identified in
eukaryotes was discovered in the yeast Saccharomyces ce-
revisiae. The complex consists of MetRS, GluRS and the
non-synthetase protein Arc1p, which has homology to the
mammalian protein p43.63,64 The association with Arc1p
was shown to increase the catalytic efficiency of the two
synthetases and enhance nuclear export of tRNA. The
bacterial homologue of Arc1p, trbp111, was first found in
the extreme thermophile Aquifex aeolicus and was shown
to promote tRNA binding by aaRSs.65,66 Factors unrelated to
the translation machinery have also been found to associate
with aaRSs. In one case a two-hybrid screen revealed inte-
raction between yeast seryl-tRNA synthetase and Pex21p, a
protein involved in peroxisome biogenesis.67 In a similar
screen yeast tyrosyl-tRNA synthetase was isolated as a pro-
tein associating with Knr4p, a protein involved in regulation
of cell wall assembly.68
In archaea much less is known about aaRS complexes,
and to date only two studies have reported their possible
existence. Methanocaldococcus jannaschii ProRS was co-
purified with the H2-forming N5-N10-methylene tetrahydro-
methanopterin dehydrogenase (HMD), a component of
the methanogenesis pathway.69 A yeast two-hybrid screen
for interactions between Methanothermobacter thermauto-
trophicus proteins, using ProRS as the bait, identified com-
ponents of methanogenesis, protein-modifying factors, and
LeuRS.70 The association of ProRS with LeuRS was confir-
med in vitro by native gel electrophoresis and size exclusion
chromatography. Determination of the steady-state kinetics
of tRNAPro charging showed that the catalytic efficiency
(kcat/KM) of ProRS increased 5-fold in the complex with
LeuRS compared to the free enzyme, while the KM for proli-
ne was unchanged. No significant changes in the steady-
state kinetics of LeuRS aminoacylation were observed on
addition of ProRS. These findings indicate that ProRS and
LeuRS associate in M. thermautotrophicus, and suggest
that this interaction contributes to translational fidelity by
enhancing tRNA aminoacylation by ProRS. Further studies
using other components of archaeal protein synthesis sug-
gest that the interaction between LeuRS and ProRS is in fact
part of a larger complex containing, both, aaRSs and other
factors.
Conclusions
Advances over the last few years have provided new in-
sights into the mechanisms that determine quality control
and fidelity during aa-tRNA synthesis. These studies have
primarily focused on the processes by which single proteins
accurately recognize cognate substrates, discriminate
against non-cognate substrates, and correct errors when
they arise. More recently it has started to become clear that
protein:protein interactions also contribute to fidelity, both,
by enhancing cognate substrate selection and expanding
substrate specificity. Investigating the mechanisms of quali-
ty control within these larger complexes, and within the
cell itself, now offers the opportunity to understand more
clearly how the cell maintains fidelity during protein syn-
thesis.
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SAÝETAK
Kontrola kvalitete pri biosintezi aminoacil-tRNA
M. Prætorius-Ibba, S. Ataide, C. Hausmann, J. Levengood, J. Ling, S. Wang,
H. Roy i M. Ibba
Vjernost translacije bitno ovisi o toènosti dvaju koraka: odabiru aminoacil-tRNA na ribosomu i
sintezi ispravnih aminoacil-tRNA pomoæu odgovarajuæih aminoacil-tRNA-sintetaza u reakciji
aminoaciliranja. NajvaÞniji dogaðaj u aminoaciliranju precizno je prepoznavanje pripadnih
supstrata (tRNA i aminokiseline) i diskriminacija nepripadnih. Iako taj posao uglavnom obavlja po
jedan enzim za svaki par tRNA : aminokiselina, nedavno smo ustanovili da su za diskriminaciju
analoga lizina potrebne dvije razlièite lizil-tRNA-sintetaze. U nekim drugim sluèajevima otkriveno
je da su pogreške u odabiru tRNA i njihovih pripadnih aminokiseline i suviše velike, pa je nuÞan
naknadni popravak pogrešnih produkata u reakciji aminoaciliranja, koji takoðer mogu katalizirati
neke aminoacil-tRNA-sintetaze. Na primjeru krivog odabira tirozina umjesto fenilalanina, te
naknadnog popravka, pokazano je kako je moguænost korekcije vaÞna u spreèavanju pogrešne
translacije genetièkog koda in vivo. Najnovija istraÞivanja pokazala su da su mehanizmi popravka
od kljuène vaÞnosti u citoplazmi, no neki se ne zbivaju u mitohondriju, ukazujuæi na smanjenu
ukupnu toènost biosinteze proteina u ovom staniènom odjeljku.
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